Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2024eJHaemOpen Access

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

View Full Paper
Ask AI
Bookmark
Share

Authors

BGB. GrønvoldMAMaryan Mohamed AliVestre Viken Hospital TrustTMTor Åge MyklebustNorwegian Institute of Public Health

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Grønvold et al. (2024) studied this question.

synapsesocial.com/papers/6a10d192cfa01e990d9f9a11https://doi.org/10.1002/jha2.842
View Full Paper
Ask AI
Bookmark
Share